EMV Capital
EMV Capital plc (formerly NetScientific plc) is an AIM-listed London deep-tech and life-sciences venture capital and corporate finance group. It invests directly off its balance sheet, manages the Evergreen EIS Fund and the Martlet Capital fund through FCA-authorised EMV Capital Partners Limited (Companies House 11412783), and syndicates co-investments. Total AUM was about GBP 104.7m at H1 2025 across over 70 portfolio companies.
Key facts
Recent exits
No exits recorded yet.
Coverage notes
1 fund tracked, 8 portfolio companies (8 active · 0 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund EMV Capital has raised, with its portfolio companies. Hand-checked from public filings.
EMV Capital Evergreen FundVC2020 · 6yr€45M8 active
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| AMR Bio | Biotech | UK | 2025 |
| Dname-iT | Software | UK | 2023 |
| EpiBone | Biotech | United States | 2020 |
| Q-Bot | TMT | UK | 2021 |
| SageTech Medical | Healthcare | UK | 2020 |
| Sofant Technologies | TMT | UK | 2019 |
| Ventive | TMT | UK | 2022 |
| Wanda Health | Healthcare | UK | 2019 |
Saved GPs appear in your watchlist, one click from your workspace.
About EMV Capital
EMV Capital is an alternative investment platform with capital deployed across 3 active fund vehicles, headquartered in London. The firm deploys capital across European mid and small-cap businesses spanning software, TMT, healthcare and consumer.
Investment thesis
The platform combines complementary investment strategies, deploying capital across software, TMT, healthcare and consumer businesses in the United Kingdom and broader European market. Multi-strategy capital deployment enables flexibility across the business lifecycle, with the partnership culture supporting management teams through growth, transmission and selective M&A across multiple fund vintages and asset classes.
Recent activity
Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 3 fund vehicles, 49 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.